Merck in talks to acquire Cubist Pharmaceuticals for more than $7 billion: NYT

(Reuters) - Merck & Co Inc is in talks to acquire Cubist Pharmaceuticals Inc for more than $7 billion in a deal that could be announced as early as next week, the New York Times reported on Friday,...